Stay updated with breaking news from Wealth Design. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Raymond James reiterated their buy rating on shares of Abbott Laboratories (NYSE:ABT – Free Report) in a report released on Wednesday morning, Stock Target Advisor reports. They currently have a $124.00 price objective on the healthcare product maker’s stock. Several other equities analysts have also weighed in on the stock. Royal Bank of Canada cut […]
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) posted its earnings results on Wednesday. The medical research company reported $5.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.70 by $0.41, reports. The firm had revenue of $10.35 billion for the quarter, compared to analysts’ expectations of $10.14 billion. Thermo Fisher […]
Prologis (NYSE:PLD – Free Report) had its price target decreased by Argus from $139.00 to $120.00 in a research report report published on Monday morning, Benzinga reports. Argus currently has a buy rating on the real estate investment trust’s stock. Several other equities analysts have also recently commented on PLD. Mizuho reaffirmed a neutral rating […]
Abbott Laboratories (NYSE:ABT – Free Report) had its target price trimmed by Barclays from $141.00 to $140.00 in a research report report published on Monday morning, Benzinga reports. The firm currently has an overweight rating on the healthcare product maker’s stock. A number of other equities analysts have also recently issued reports on ABT. Citigroup […]
First National Bank Sioux Falls grew its position in Avantis International Equity ETF (NYSEARCA:AVDE – Free Report) by 20.9% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 149,040 shares of the company’s stock after purchasing an additional 25,782 shares during the period. Avantis International Equity ETF makes up 4.6% of First National Bank […]